Campbell & CO Investment Adviser LLC

Position in NVS — Novartis AG

CIK 1353570 BALTIMORE, MD

Position in NVS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$6,055,926

+$2,661,705 QoQ

Shares Held

39,646

+61.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.35%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Campbell & CO Investment Adviser LLC holds $29,502,691 across 9 Drug Manufacturers - General names. NVS ranks #3 (20.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	50,560	$7,046,547
2	LLY	ELI LILLY & Co	7,041	$6,476,100
3	NVS	Novartis AG This page	39,646	$6,055,926
4	AMGN	Amgen Inc	14,110	$4,964,603
5	BMY	Bristol Myers Squibb Co	29,424	$1,784,565
6	AZN	Astrazeneca PLC	8,338	$1,644,420
7	OGN	Organon & Co.	128,309	$768,570
8	GRFS	Grifols SA	63,848	$512,060

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,055,926	39,646	+61.0%	Shares	Sole	2026-05-15
2025-12-31	$3,394,221	24,619	+64.8%	Shares	Sole	2026-02-12
2025-03-31	$1,665,511	14,940	-85.0%	Shares	Sole	2025-05-14
2024-12-31	$9,693,438	99,614	+921.6%	Shares	Sole	2025-02-10
2024-09-30	$1,121,560	9,751	-35.4%	Shares	Sole	2024-11-12
2024-06-30	$1,608,184	15,106	+41.7%	Shares	Sole	2024-08-13
2024-03-31	$1,031,528	10,664	+259.4%	Shares	Sole	2024-05-10
2023-12-31	$299,577	2,967	-76.4%	Shares	Sole	2024-02-13
2023-06-30	$1,270,255	12,588	+72.3%	Shares	Sole	2023-08-11
2023-03-31	$671,968	7,304	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.